世界银行：2026年突尼斯高血压和糖尿病治疗连锁成本报告（英文版）

Hypertension and diabetes are the most prevalent diseases in Tunisia and rank among the costliest both to the health system and to the economy—second only to tumours. There are currently an estimated 3.3 million people living with hypertension and 1.7 million people living with Type-2 diabetes (T2D) in Tunisia, of whom 1.2 million are treated for hypertension and 0.9 million people are treated for diabetes. Nevertheless, there is limited granular information regarding the cost of the hyperten